IV Cannula Manufacturing Business in India
Despite having a strong engineering and plastics manufacturing capability in the country, India imports more than 60 percent of its IV-cannula supply from China and Malaysia with a market size of over Rs 1,200 crore and expanding at 12-15 percent a year. This is one of the highest volume disposable medical devices used in India’s healthcare system as every hospital admission with IV therapy (hundreds of millions of episodes annually) necessitates a new cannula. According to Invest India Medical Devices sector report, IV cannulas are one of the top-10 priority import substitution products being promoted by the PLI scheme and preferential government procurement policies by the Government of India.
Market Opportunity: Why This Business Cannot Be Ignored
As India’s healthcare infrastructure expands at a fast pace, with the Ayushman Bharat PMJAY bringing more than 28,000 hospitals onto the map, their growing number is creating a demand for IV cannulas that domestic manufacturers cannot keep up with. This dependency on imports makes the hospital buyer vulnerable to supply disruption and currency if prices rise and puts pressure on the exporting price of the well-certified domestic manufacturer to supply to CDSCO Class C standards on time and at competitive prices.
The IBEF India Medical Devices Market Report states that the medical devices sector is growing at 15% CAGR in India and IV cannula is a product which has been identified as a high-priority import substitution product with high demand in domestic and export markets. The quality standards, approved gauge ranges and preferred gauge ranges for vendors to be considered for supply to NHM district hospitals by CDSCO Class C manufacturers are published on the National Health Mission procurement portal.
AIMED (Association of Indian Medical Device Industry) estimates that India is importing more than 60 per cent of its requirement for IV cannula, which is an attractive import substitution opportunity. By building to the ISO 13485 standards, the entrepreneur can carve out lucrative margins on the two sides of this split market – from the government tender route on GeM and the branded supply to hospitals – and simultaneously be able to help bring India closer to its objective of becoming self-reliant with medical devices.
Get Detailed Insights from This Book: Medical and Surgical Disposable Products Handbook
Industry Analysis: Growth Drivers and Demand Outlook
Indian market for Indian IV cannula is estimated to be Rs 1,200 crore and is projected to grow at 12-15 percent CAGR. With the registration on the Government e-Marketplace (GeM) the NHM, CGHS and defence hospital procurement tenders will be made available in a very transparent manner, giving a huge steady institutional revenue stream to any domestic manufacturer whose products are CDSCO Class C certified, who can also demonstrate competitive pricing and quality consistency.(IV Cannula Manufacturing Business in India)
IV cannulas have potential to be exported to Middle East, Africa and South East Asia markets, too, in India. The medical devices sector initiative, make in India, is actively encouraging domestic medical devices manufacturers by providing production linked incentives and Indian IV cannulas that are CE-marked or have ISO 13485 certification are competitive with European imports in developing-world hospital markets where price is a significant factor.
India IV Cannula Market Overview
| Parameter | Market Data | Notes |
| India Market Value | Approx. Rs 1,200 crore | Industry estimates |
| Market Growth Rate | 12-15% CAGR | Hospital bed addition driven |
| Import Dependency | 60%+ from China and Malaysia | AIMED industry data |
| CDSCO Classification | Class C Medical Device | MDR 2017 India |
| Gauge Range in Use | 14G to 24G (various lengths) | Standard clinical practice |
| Key Government Buyer | NHM, PMJAY hospitals, CGHS | GeM procurement portal |
| Major Indian Manufacturers | Romsons, SURU International, Mediplus | Listed manufacturers |
How to Start: Step-by-Step Guide for Entrepreneurs
Step 1: Company Registration and MSME Enrolment
Register your Manufacturing Organisation (OPC, LLP or Private Ltd) and Register for the Udyam portal to avail MSME benefits. Make application for factory licence and get GST registration. Industrial land in a state MIDC, GIDC or UPSIDC estate offers low utility costs and quick connections to utilities, and is eligible for state capital subsidy schemes. All the new IV Manufacturing Units should register on the Udyam MSME Registration Portal to avail PMEGP, CGTMSE and state capital subsidy schemes which will help in reducing the net equity investment for establishing a plant to manufacture IV which will comply with CDSCO Class C.(IV Cannula Manufacturing Business in India)
Get Detailed Project Report (DPR): IV Cannula Manufacturing Plant Report
Step 2: CDSCO Class C License and ISO 13485 Certification
Step 3: Plant Setup: FEP Tubing and Injection Moulding
Key machines encompass FEP tubing extrusion machines for the cannula body, PVC injection moulding for hub and flashback chamber, automated assembly and needle insertion machines, and individual machines for sealing blisters. The Grade D or ISO Class 8 clean room requirements for assembly and packaging are for an area of around 2,000 to 4,000 sq ft as mandated by CDSCO GMP.
Step 4: Raw Material Procurement and QC Testing
The main raw materials include FEP or polyurethane (PUR) tubing for the cannula body, medical grade polypropylene for hub and flashback chamber, gamma permeable blister packaging for the package, and SS304 or SS316L steel for the introducer needle (trocar). The in-house QC testing should include tip sharpness, straightness of the needles, tip bevel geometry, seal integrity, and confirmation of biocompatibility testing based on ISO 10993.(IV Cannula Manufacturing Business in India)
Step 5: GeM Registration, Institutional Sales, and Export
Apply for Registration in GeM (gem.gov.in) for domestic government procurement through NHM, CGHS and defence hospitals. The private hospital procurement should be done through institutional medical distributors where there is marked difference between the price of the product and the tender-only price with respect to quality premiums. To penetrate the hospital supply markets in the Gulf, Africa and Southeast Asia, subject it to CE marking under EU MDR 2017 or ISO 13485 certification. The export market development process is supported by a Pharmexcil (Pharmaceuticals Export Promotion Council) that arranges and holds buyer-seller’s meetings and allows manufacturers of IV cannula to attend Arab Health and Med Africa trade exhibitions.
Your investment deserves the right opportunity</
Project Investment Breakdown (Small to Medium Scale)
| Cost Item | Estimated Amount (INR) | Notes |
| Industrial shed lease or construction | Rs 10 – 18 lakhs per year | Minimum 3,000 sq ft |
| FEP tubing extrusion machine | Rs 20 – 35 lakhs | Core cannula body equipment |
| Injection moulding machine (hub, flashback) | Rs 15 – 25 lakhs | 1-2 machines required |
| Assembly and needle insertion machine | Rs 15 – 30 lakhs | Semi or fully automated |
| Blister sealing and labelling line | Rs 8 – 15 lakhs | Packaging line |
| Clean room construction (Grade D) | Rs 10 – 18 lakhs | CDSCO Class C GMP requirement |
| QC lab and testing instruments | Rs 5 – 8 lakhs | Sharpness, sterility, dimensional |
| Raw material stock (1 month) | Rs 12 – 20 lakhs | FEP tubing, PP resin, SS trocar |
| CDSCO Class C licensing and ISO 13485 | Rs 5 – 9 lakhs | Regulatory and QMS |
| Working capital (3 months) | Rs 15 – 25 lakhs | Salaries, power, overheads |
| TOTAL PROJECT COST | Rs 1.15 – 2.03 crore | Scales to Rs 4Cr+ for larger plant |
Related Article: How to Start an IV Cannula Manufacturing Unit: A Complete Business Guide
Financial Projections and Profitability
If the blended pricing is considered for both government tender and hospital, a medium scale IV cannula unit with an annual capacity of 1 million can generate Rs 6-10 crore annually. According to FICCI’s Medical Technology Sector Report, net operating margins of 15-22 percent are achievable in the precision medical device manufacturing after raw material cost, clean room operation cost and quality compliance, the payback period is normally 3-5 years.(IV Cannula Manufacturing Business in India)
Units that are set to export fetch a premium of 15-25 percent over domestic tenders and avail duty drawback and RoDTEP incentives. It can be heard that manufacturers registered under Federation of Indian Export Organisations (FIEO) can avail export opportunities in Gulf, African and South East Asian markets for the IV cannula, which is the major demand segment in hospitals in the country as the medical infrastructure is expanding with a good growth rate in the country and there is a significant market opportunity in the foreign markets as well. IV cannula exporters can avail duty refund benefits on eligible exports to the markets of the Gulf, Africa, and the Directorate General of Foreign Trade RoDTEP portal which can enhance their net export margins by 2-4 per cent per shipment.
Government Schemes and Incentives for Medical Manufacturers
| Cost Item | Estimated Amount (INR) | Notes |
| Industrial shed lease or construction | Rs 10 – 18 lakhs per year | Minimum 3,000 sq ft |
| FEP tubing extrusion machine | Rs 20 – 35 lakhs | Core cannula body equipment |
| Injection moulding machine (hub, flashback) | Rs 15 – 25 lakhs | 1-2 machines required |
| Assembly and needle insertion machine | Rs 15 – 30 lakhs | Semi or fully automated |
| Blister sealing and labelling line | Rs 8 – 15 lakhs | Packaging line |
| Clean room construction (Grade D) | Rs 10 – 18 lakhs | CDSCO Class C GMP requirement |
| QC lab and testing instruments | Rs 5 – 8 lakhs | Sharpness, sterility, dimensional |
| Raw material stock (1 month) | Rs 12 – 20 lakhs | FEP tubing, PP resin, SS trocar |
| CDSCO Class C licensing and ISO 13485 | Rs 5 – 9 lakhs | Regulatory and QMS |
| Working capital (3 months) | Rs 15 – 25 lakhs | Salaries, power, overheads |
| TOTAL PROJECT COST | Rs 1.15 – 2.03 crore | Scales to Rs 4Cr+ for larger plant |
PMEGP (KVIC/MSME)25-35% capital subsidy, max Rs 25 lakh for manufacturingNew micro and small unitsCGTMSE (SIDBI)Collateral-free loans up to Rs 5 crore for MSMEsAll MSME manufacturersPLI – Medical Devices4-6% production-linked incentive on incremental salesApproved device manufacturersStartup India (DPIIT)3-year income tax holiday, fast-track regulatory supportDPIIT-recognised startupsState MSME Capital Subsidy15-25% subsidy on plant and machinery (varies by state)State-notified MSME unitsSIDBI MSME LoansConcessional term loans for equipment and capacity expansionAll small manufacturers
Entrepreneur Spotlight
Meena Krishnamurthy | Coimbatore, Tamil Nadu
Mechanical engineer Meena Krishnamurthy, whose previous work experience was in precision component manufacturing, switched to the production of IV cannula due to the gap in supply during the COVID pandemic. She established a 6000 Sq. Ft. Unit at TIDCO Industrial Estate, Coimbatore with an initial investment of Rs.1.45 crore availed through a 90% term loan from CGTMSE and the Tamil Nadu State Government’s capital subsidy for MSMEs.(IV Cannula Manufacturing Business in India)
Meena has been awarded CDSCO Class C licensing, ISO 13485 certification, and GeM registration, and is now providing 3 lakh IV cannulas to 14 government hospitals through a tender from Tamil Nadu Medical Services Corporation, in addition to negotiating her first export shipment to a hospital distributor in Nigeria.
How NPCS Supports Your Business Launch
Niir Project Consultancy Services (NPCS) has been involved in the preparation of more than 8,000 Detailed Project Reports (DPRs) in more than 45 years in various industrial sectors such as medical devices and hospital disposables. The NPCS DPR includes plant layout, details of machinery, contacts with suppliers, sourcing of raw materials, pathway for CDSCO licensing, financial projections, and bank ready investment analysis for manufacturing of IV cannula and peripheral catheter.
A NPCS DPR also helps entrepreneurs with the application of various government schemes, export registrations and quality certification roadmaps tailored to their state and scale. For project reports from this sector, visit niir.org and for sector case studies and investment analysis, browse through Entrepreneur India magazine at entrepreneurindia.co.(IV Cannula Manufacturing Business in India)
Key Reference Links and Further Reading
AIMED – Association of Indian Medical Device Industry: https://www.aimed.info
Make in India – Medical Devices Sector: https://www.makeinindia.com/sector/medical-devices
Government e-Marketplace (GeM): https://gem.gov.in
FIEO – Federation of Indian Export Organisations: https://www.fieo.org
Frequently Asked Questions
Q: IV cannula is a product classified under Class II (Intermediate) of CDSCO.
IV Cannulas (peripheral intravenous catheters) fall under the category of Class C medical devices as per Medical Devices Rules 2017, India. A manufacturing licence is required from CDSCO in New Delhi and not just from State Licensing Authority for Class C. For Class C devices, effectively, ISO 13485 quality management certification is required as part of the CDSCO approval process.
Q: What is the least investment needed for a manufacturing plant of IV Cannula?
A: It takes Rs 1.15 Crore to Rs 2 Crore to establish a small scale IV cannula unit, which includes the cost of FEP tubing extrusion, injection moulding machines, assembly machines, clean room, raw material stock and working capital. Support for CGTMSE by way of collateral-free loan and state capital subsidy can drastically cut down the equity requirement of the promoter.
Q: The raw materials used in the manufacture of IV cannulas are silicone, stainless steel, or glass.
A: Key raw materials include FEP or polyurethane (PUR) tubing for the catheter body, medical grade polypropylene for the hub and flashback chamber, SS304 or SS316L wire for the introducer needle (trocar), and gamma permeable blister packaging. Specialty tubing can be imported from Europe or Taiwan or obtained from domestic suppliers, polypropylene or steel.
Q: How many cannulas does a small IV cannula plant make a day?
The typical assembly line for a semi-automated IV cannula is 10,000 to 30,000 pieces per shift depending on the mix of gauge size IVs being produced. If the 8-hour shift generates 20,000 pieces, then it is enough to produce Rs 3-5 crore in institutional prices per month, or about 7.2 lakh units per year.
Q: Class B and C are medical devices.Q: How is Class B medical device different from Class C?
A: Class B devices (such as syringes) are licensed by the State Licensing Authority (SLA) of the State where the unit is used. Class C devices (like IV cannulas) require a manufacturing licence from CDSCO centrally.
Q: NPCS can assist you in planning your business to manufacture IV cannula.
A: NPCS does Detailed Project Reports for medical device makers such as IV cannula units. We have prepared a DPR that includes detailed information regarding the specifications of the FEP extrusion line, clean room design to CDSCO Class C GMP standards, CDSCO licensing documentation checklist, ISO 13485 QMS framework, machinery list with contacts of vendors, and complete financial projections that fit the bank loan application. For information about the project reports available, please visit niir.org.
Conclusion
The IV-cannula manufacturing industry is in the cross section of import substitution, expansion of the healthcare infrastructure, and expanded government procurement. Invest India’s medical device sector analysis projects that the domestic medical devices market will reach USD 50 billion by 2030. IV cannulas, which fall under the Class C segment, are among the highest-value and fastest-growing import substitution segments in this growth.
